Neuland Laboratories soars on receiving EIR from USFDA for Bonthapally facility

03 Sep 2019

Neuland Laboratories is currently trading at Rs. 475.00, up by 13.70 points or 2.97% from its previous closing of Rs. 461.30 on the BSE.

The scrip opened at Rs. 460.00 and has touched a high and low of Rs. 481.15 and Rs. 460.00 respectively. So far 486 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 824.55 on 26-Feb-2019 and a 52 week low of Rs. 431.45 on 11-Dec-2018.

Last one week high and low of the scrip stood at Rs. 483.30 and Rs. 444.00 respectively. The current market cap of the company is Rs. 591.84 crore.

The promoters holding in the company stood at 35.90%, while Institutions and Non-Institutions held 37.78% and 26.32% respectively.

Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Bonthapally, Hyderabad. The facility was inspected from June 17, 2019 to June 21, 2019.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Related Neuland Laboratories Ltd. Links:

Neuland Laboratories Share Price

509.25 0.00 (0.00%) Nov 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 410.05
Lupin 738.25
Dr. Reddys Lab 2734.00
Piramal Enterprises 1758.75
Cadila Healthcare 234.20
View more..
Sensex vs Neuland Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463